SEISMiQ: de novo impurity structure elucidation from tandem mass spectra boosts drug development

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is an essential analytical technique in the pharmaceutical industry, used particularly for elucidating the structure of unknown impurities in the synthesis of active pharmaceutical ingredients. However, the interpretation of mass spectra is challenging and time-consuming, requiring significant expertise. While recent computational tools aimed at automating this process have been developed, their accuracy in determining the chemical structure is limited. In this paper, we introduce a new method for elucidating unknown impurities from their MS/MS spectra. We are able to significantly improve elucidation accuracy by integrating domain experts’ knowledge, specifically the impurity sum formula and known substructure, into the model's training and inference process. Further performance improvements can be achieved through transfer learning from simulated MS/MS spectra of impurities from an in-house database. Finally, the need for any experimental data collection for finetuning can be circumvented by simulating the entire drug substance synthesis process in silico via reaction templates.